Liminatus Pharma, Inc. (LIMN)
Liminatus Pharma Market Cap : 5.738M for March 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CDT Equity, Inc. | 1.121M |
| LENZ Therapeutics, Inc. | 327.92M |
| Oruka Therapeutics, Inc. | 1.928B |
| Maze Therapeutics, Inc. | 2.311B |
| MapLight Therapeutics, Inc. | 796.75M |
Market Cap Related Metrics
| PEG Ratio | -0.0333 |
| Price | 0.212 |
| Earnings Yield | -87.41% |
| PEGY Ratio | -0.0333 |